Publications

5803 Results

Minority participant accrual workshops-innovative strategy to increase African American accrual

Authors
RD Campbell
Journal / Conference
Clinical Trials 2(Suppl 1):S81 (#P80)
Year
2005
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

The black church: an invaluable ally for enhancing minority recruitment

Authors
JM Harrington;S Hamilton;R Campbell;S Moon;E Cook
Journal / Conference
Clinical Trials 2(Suppl 1):S24 (#05)
Year
2005
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Mutational analysis of K-RAS and EGFR implicates K-RAS as a resistance marker in the Southwest Oncology Group (SWOG) trial S0126 of bronchioalveolar carcinoma (BAC) patients (pts) treated with gefitinib

Authors
PH Gumerlock;WS Holland;H Chen;WA Franklin;FR Hirsch;PC Mack;AM Davies;J McCoy;HJ West;DR Gandara
Journal / Conference
Proc of the ASCO, JCO 23(16S):623s (#7008)
Year
2005
Research Committee(s)
Lung
Study Number(s)
S0126

The Southwest Oncology Group (SWOG) young investigators training program (YITP), a practical experience

Authors
Z Nahleh;AR Jazieh;D Sparks;J Benedetti
Journal / Conference
Journal of Cancer Education 20(3) Suppl:15 (#13)
Year
2005

Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American intergroup 0139 (RTOG 9309)

Authors
KS Albain;RS Swann;VR Rusch;AT Turrisi;FA Shepherd;CJ Smith;DR Gandara;DH Johnson;MR Green;RC Miller
Journal / Conference
Proc of the ASCO, JCO 23(16S):624s (#7014)
Year
2005
Research Committee(s)
Lung
Study Number(s)
SWOG-9336

Low incidence of pneumonitis on SWOG 0023: a preliminary analysis of an ongoing phase III trial of concurrent chemoradiotherapy followed by consolidation docetaxel and gefitinib/placebo maintenance in patients with inoperable stage III non-small cell lung cancer

Authors
K Kelly;LE Gaspar;K Chansky;KS Albain;J Crowley;DR Gandara
Journal / Conference
Proc of the ASCO, JCO 23(16S):634s (#7058)
Year
2005
Research Committee(s)
Lung
Study Number(s)
S0023

SWOG/Intergroup 9623: a phase III comparison of intensive sequential chemotherapy to high dose chemotherapy and autologous hematopoietic progenitor cell support (ACHPCS) for primary breast cancer in women with >4 involved axillary lymph nodes.

Authors
SI Bearman;SJ Green;J Gralow;W Barlow;C Hudis;A Wolff;J Ingle;G Hortobagyi;R Livingston;S Martino
Journal / Conference
Proc of the ASCO, JCO 23(16S):21s (#572)
Year
2005
Research Committee(s)
Breast
Study Number(s)
S9623

Optimal combined modality treatment improves outcome of locally advanced bladder cancer: analyis of SWOG 8710

Authors
ZA Dotan;DF Bajorin;BH Grossman;HW Herr
Journal / Conference
Proc of the ASCO, JCO 23(16S):385s (#4531)
Year
2005
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)

Dose-dense (DD)AC followed by paclitaxel is associated with moderate frequent anemia compared to sequential (S) and/or less DD Treatment: update by CALGB on breast cancer intergroup trial C9741 with ECOG, SWOG, & NCCTG

Authors
ML Citron;DA Berry;C Cirrincione;RB Livingston;W Gradishar;E Perez;H Muss;L Norton;E Winer;C Hudis
Journal / Conference
Proc of the ASCO, JCO 23(16S):33s (#620)
Year
2005
Research Committee(s)
Breast
Study Number(s)
C9741

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17

Authors
PE Goss;JN Ingle;S Martino;NJ Robert;HB Muss;MJ Piccart;M Castiglione;D Tu;LE Shepherd;KI Pritchard;RB Livingston;NE Davidson;L Norton;EA Perez;JS Abrams;DA Cameron;MJ Palmer;JL Pater
Journal / Conference
Journal of the National Cancer Institute 97(17):1262-1271
Year
2005
Research Committee(s)
Breast
Study Number(s)
JMA17